• 한국전기전자재료학회:학술대회논문집
• /
• 한국전기전자재료학회 2002년도 하계학술대회 논문집
• /
• pp.232-235
• /
• 2002

An 150 kV gas cluster ion accelerator was fabricated and assessed. The change of surface morphology and surface roughness were examined by an atom force microscope (AFM) after irradiation of $CO_2$ gas clusters on Si (100) surfaces at the acceleration voltages of 50 kV. The density of hillocks induced by cluster ion impact was gradually increased with the dosage up to 5$\times$10$^{11}$ ions/$\textrm{cm}^2$. At the boundary of the ion dosage of 10$^{12}$ ions/$\textrm{cm}^2$, the density of the induced hillocks was decreased and RMS (root mean square) surface roughness was not deteriorated further. At the dosage of 5x10$^{13}$ ions/$\textrm{cm}^2$, the induced hillocks completely disappeared and the surface became very flat. In addition, the irradiated region was sputtered. $CO_2$ cluster ions are irradiated at the acceleration voltage of 25 kV to remove hillocks on indium tin oxide (ITO) surface and thus to attain highly smooth surfaces. $CO_2$ monomer ions are also bombarded on the ITO surface at the same acceleration voltage to compare sputtering phenomena. From the AFM results, the irradiation of monomer ions make the hillocks sharper and the surfaces rougher On the other hand, the irradiation of $CO_2$ cluster ions reduces the hight of hillocks and planarize the ITO surfaces. From the experiment of isolated cluster ion impact on the Si surfaces, the induced hillocks m high had the surfaces embossed at the lower ion dosages. The surface roughness was slightly increased with the hillock density and the ion dosage. At higher than a critical ion dosage, the induced hillocks were sputtered and the sputtered particles migrated in order to fill valleys among the hillocks. After prolonged irradiation of cluster ions, the irradiated region was very flat and etched.

• 대한약침학회지
• /
• 제19권2호
• /
• pp.155-162
• /
• 2016

Objectives: Bufonis venonum (BV) is toad venom and is the dried, white secretions of the auricular and the skin glands of toads. This study was performed to evaluate the toxicity of intravenous injection of Bufonis venonum pharmacopuncture (BVP) through a single-dose test with sprague-dawley (SD) rats. Methods: Twenty male and 20 female 6-week-old SD rats were injected intravenously in the caudal vein with BVP or normal saline. The animals were divided into four groups with five female and five male rats per group: the control group injected with normal saline, the low-dosage group injected with 0.1 mL/animal of BVP, the medium-dosage group injected with 0.5 mL/animal of BVP and the high-dosage group injected with 1.0 mL/animal of BVP. We performed clinical observations every day and body weight measurements on days 3, 7 and 14 after the injection. We also conducted hematology, serum biochemistry, and histological observations immediately after the observation period. Results: No mortalities were observed in any experimental group. Paleness occurred in the medium- and the high-dosage groups, and congestion on tails was observed in females in the medium- and the high-dosage groups. No significant changes in weight, hematology, serum biochemistry, and histological observations that could be attributed to the intravenous injection of BVP were observed in any experimental group. Conclusion: The lethal dose of intravenously-administered BVP in SD rats is over 1.0 mL/animal.

• 한국산학기술학회논문지
• /
• 제16권3호
• /
• pp.2321-2327
• /
• 2015

본 연구는 급격한 수질변화에 따른 현장 적용에 적합한 응집제를 선정하고, 응집제 별 최적 주입량을 찾기 위해 aluminium sulfate, poly aluminum chloride, poly aluminum silicate chloride를 이용하여 Jar-Test와 Pilot-Test의 검증으로 실험 하였다. 분석 항목은 탁도, TOC, pH로 제거율을 측정하였다. 실험 결과를 바탕으로 PASC의 경우 기존 응집제 인 Alum이나 PAC 보다 최적 주입량 (15 mg/L)이 상대적으로 적었으며, 제거율도 높게 나타남을 확인할 수 있었다. Jar-Test에서는 원수 탁도 3-20 NTU 범위에서 응집제(PASC)의 최적 주입량을 주입하였을 때, 탁도 제거율(80%)과 TOC 제거율(89%)이 가장 높았으며, Pilot-Test에서는 원수 탁도 3.6-27 NTU 범위에서 응집제 최적 주입량을 주입하였을 때 탁도 제거율(82%)과 TOC 제거율(88%)을 확인할 수 있었다. 따라서 본 연구 결과를 바탕으로 응집제의 제거 효과는 원수 탁도와 TOC가 높아질수록 상승하는 경향을 확인할 수 있었다.

• Journal of Pharmaceutical Investigation
• /
• 제34권3호
• /
• pp.229-254
• /
• 2004

The objective of this study was to scrutinize the rationale of SUPAC-MR and its application in processing postapproval changes to modified release solid oral dosage forms. The types of postapproval changes that were primarily covered with SUPAC-MR included variations in the components and composition, the site of manufacturing, batch size, manufacturing equipment, and manufacturing process. SUPAC-MR defined levels of postapproval changes that the industry might make. Classification of such categories was based on the likelihood of risk occurrence and potential impact of changes upon the safety and efficacy of approved drug products. In most cases, the changes could be classified into 3 levels. It described what chemistry, manufacturing, and control tests should be conducted for each change level. The important tests specified in SUPAC-MR were batch release, stability, in vitro dissolution, and in vivo bioequivalence tests. It then suggested what type of a filing report should be submitted to the FDA for each change level. In general, level 1 changes could be reported in an annual report, whereas level 2 and/or 3 changes could be submitted in changes-being-effected or prior approval supplements. It could be understood that the purpose of SUPAC-MR was to maintain the safety and quality of approved modified release solid oral dosage forms undergoing certain changes. At the same time, it contributed to providing a less burdensome regulatory process with the manufacturers when they wanted to make postapproval changes. European regulatory agencies also implemented SUPAC-like regulations in handling such changes to drug products. Therefore, in this study a recommendation was made for KFDA and the Korean industry to evaluate thoroughly the usefulness of these guidances and regulations in dealing with postapproval changes to modified release solid oral dosage forms.

• 대한약침학회지
• /
• 제14권1호
• /
• pp.5-24
• /
• 2011

Objective: This study was performed to analyse four weeks repeated -dose toxicity of Sweet Bee Venom (SBV-pure melittin, the major component of honey bee venom) in rats. Methods: All experiments were conducted under the regulations of Good Laboratory Practice (GLP) at Biotoxtech Company, a non-clinical study authorized institution. Male and female rats of 5 weeks old were chosen for the pilot study of four weeks repeated-dose toxicity and was injected at the level of 0.56 mg/kg body weight (eighty times higher than the clinical application dosage as the high dosage), followed by 0.28 and 0.14 mg/kg as midium and low dosage, respectively. Equal amount of normal saline was injected as the control group every day for four weeks. Results: 1. No mortality was witnessed in all of the experiment groups. 2. All experiment groups appealed pain sense in the treating time compared to the control group, and side effects such as hyperemia and movement disorder were observed around the area of injection in all experiment groups, and the higher dosage in treatment, the higher occurrence in side effects. 3. Concerning weight measurement, neither male nor female groups showed significant changes compared to the control group. 4. Concerning to the CBC and biochemistry, all experiment groups didn't show any significant changes compared to the control group. 5. Concerning weight measurement of organs, experiment groups didn't show any significant changes compared to the control group. 6. To verify abnormalities of organs and tissues, those such as cerebellum, cerebrum, liver, lung, kidney, and spinal cords were removed and we conducted histologocal observation with H-E staining. Concerning the histologocal observation of liver tissues, some fatty changes were observed around portal vein in 0.56 mg/kg experiment group. But another organs were not detected in any abnormalities. 7. The proper high dosage of SBV for the thirteen weeks repeated test in rats may be 0.28 mg/kg in one time. Conclusion: Above findings suggest that SBV is relatively safe treatment medium. Further studies on the subject should be conducted to yield more concrete evidences.

• Environmental Engineering Research
• /
• 제17권1호
• /
• pp.17-25
• /
• 2012

Concern about green water problem has surfaced as a serious issue in Korea. In order to solve this problem, it is necessary to research inhibition of green water and corrosion control of copper pipe in water service. This paper discovered that moderate corrosion inhibitors can solve the green water problem and copper corrosion in water service by adding the optimal concentration of corrosion inhibitors based on regulation. Firstly, in the case of phosphate based corrosion inhibitors, as dosage of the corrosion inhibitor increases from 1 mg/L to 5 mg/L, the relative effect of corrosion inhibitor declines rapidly. Secondly, except for 1 mg/L dosage of silicate based inhibitor, relative effects of the inhibitor displays a positive number depending on inhibitor concentration. The most significant result is that the amount of copper release shows a downward trend, whereas the phosphate based inhibitor accelerates copper ion release as the inhibitor dosage increases. Thirdly, as the dosage of mixed inhibitors increases to 10 mg/L, the copper release change shows a similar trend of phosphate based inhibitor. Lastly, according to the Langelier saturation index (LI), silicate based inhibitors have the most non corrosive value. Larson ratio (LR) indicates that phosphate based inhibitors are the least corrosive. Korea water index (KWI) represents that silicate based inhibitors are most effective in controlling copper pipe corrosion.

• Toxicological Research
• /
• 제12권1호
• /
• pp.113-119
• /
• 1996

Group of 40 male and 40 female Sprague-Dawley rats was given daily intravenous injections of different dosage of Ginkgo biloba extract(EGb 761), 7.5 mg/kg/day (low dosage group), 15 mg/kg/day (middle dosage group), or 30 mg/kg/day (high dosage group)for 3 month by tail vein according to Established Regulation of Korean National Institute of Safety Research (1994. 4. 14). Appearance, behavior, mortality, and food consumption of rats of treated groups were not affected during the experimental periods. No significant Ginkgo biloba extract(EGb 761)-related changes were found in urinalysis, hematology, serum chemistry, and organ weight. No histopathological lesions were seen in both control and treatment groups. Our results strongly suggest that no toxic changes were found in rat treated intravenously with Ginkgo biloba extract(EGb 761)for 3 month.

• Toxicological Research
• /
• 제12권1호
• /
• pp.121-128
• /
• 1996

Group of 12 male and 12 female rabbits was given daily intravenous injections of different dosage of Ginkgo biloba extract(EGb 761), 7.5 mg/kg/day (low dosage group), 15 mg/kg/day (middle dosage group), or 30 mg/kg/day (high dosage group)for 3 month by ear vein according to Established Regulation of Korean National Institute of Safety Research (1994. 4. 14). Appearance, behavior, mortality, and food consumption of rabbits of treated groups were not affected during the experimental periods. No significant Ginkgo biloba extract(EGb 761)-related changes were found in urinalysis, hematology, serum chemistry, and organ weight. No histopathological lesions were seen in both control and treatment groups. Our results strongly suggest that no toxic changes should be found in rabbit treated intravenously with Ginkgo biloba extract(EGb 761)for 3 month.

• 상하수도학회지
• /
• 제10권4호
• /
• pp.55-63
• /
• 1996

This research was based on comparing ozonation with combined ozone/ultraviolet oxidation through the methods of reducing THM produced during water treatment. The results were as follows ; 1. The decline of THM concentration was appeared according as ozone dosage increases with ozonation and combined ozone/ultraviolet oxidation. The more effective method was the treatment of irradiating UV then ozonation. In the beginning of reaction the decline rate of THM formation potential was low, I thought it was because that the reaction of ozone and humic acid needed times to be steady state, or that THM formation potential existed according to humic acid. 2. The effect of combined ozone/ultraviolet oxidation when ozone dosage was 4.2mg/L min was almost the same that of ozonation when ozone dosage was 8.6mg/L min. 3. In experiment of TOC decline through ozonation and combined ozone/ultraviolet oxidation, TOC concentration was also dropped according to increasing ozone dosage and the more effective results were showed in treatment of irradiating UV than ozonation. But the similar TOC remove rates were showed in experiment of changing with ozone dosage during combined ozone/ultraviolet oxidation TOC remove rates were low in proportion to the remove rates of THM formation potential, it was considered that humic acid was made low molecule itself though ozonation and ozone/ultraviolet oxidation. Moreover, the high degree of remove efficiency will be get though the treatment of activated carbon of GAC treatment after combined ozone/ultravilet oxidation.

• 한국환경과학회지
• /
• 제7권6호
• /
• pp.761-772
• /
• 1998

상수원수의 효과적인 처리를 위한 최적 응집제 주입량을 결정하기 위하여 상수원수의 콜로이드성 오염물질 처리를 위한 Alum, PAC 및 PACS의 응집제 주입량별 탁도제거 및 원수특성변화를 조사한 결과는 다음과 같다. 최저 잔류탁도를 나타내는 최적 응집제 주입량은 원수의 탁도가 5NTU인 경우 Alum은 35mg/ι, PAC은 30mg/ι 및 PACS는 10mg/ι이었고, 원수의 탁도가 10NTU인 경우 Alum은 30mg/ι, PAC은 25mg/ι 및 PACS는 10mg/ι이었으며, 이때 침전시간 4분 및 8분대의 탁도제거율은 원수탁도 5NTU인 경우 Alum은 10 및 72%, PAC은 44 및 62%, PACS는 25 및 55%였고, 원수탁도 10NTU인 경우에는 Alum은 52 및 70%, PAC는 90 및 95%, PACS은 10 및 28%였다. PAC이 Alum 및 PACS에 비하여 floc형성속도와 침강성이 우수하고 탁도제거율도 높게 나타나 침전지내급수량 변동이 심하고 표면부하율이 과부하일 경우 PAC을 사용하는 것이 유리할 것으로 판단되었다. 원수의 탁도별 응집제 주입량에 따른 pH 및 알칼리도는 응집제 주입량이 증가할수록 감소되었으나 각 응집제 최대 주입량에서 pH는 음용수 수질기준인 pH 5.8이하로는 감소되지 않았으며, 알칼리도도 재탁현상이 일어날 수 있는 10mg/ι 이하로는 감소되지 않았다. 처리수준 잔류 Al은 원수탁도 5 및 10NTU인 경우 Alum과 PAC은 그 주입량이 저농도에서 고농도로 갈수록 잔류탁도가 감소함으로써 잔류 Al도 감소하였으나 PACS는 잔류탁도가 증가하는 주입량에서도 잔류 Al은 감소하였다. 수중 KMnO$_4$ 소비량은 응집제 주입량이 증가할수록 감소되었으며, 최저 잔류 탁도를 나타내는 최적 응집제 주입량에서의 KMnO$_4$ 소비량 감소율은 원수탁도 5NTU일 경우 PAC 39%, Alum 18% 및 PACS 11%였으며, 10NTU일 경우에는 PAC 42%, Alum 27% 및 PACS 36%로서 전반적으로 탁도제거율과 KMnO$_4$소비량간에는 일정한 경향이 없는 것으로 나타났다. 수중 TOC는 응집제 주입량이 증가함에 따라 약간씩 감소되었으나 응집제 주입량 30mg/ι 이후부터는 일정 수준으로 유지되었으며, 감소되는 정도는 PACS ＞PAC ＞Alum순이었다. 최저 잔류탁도를 나타내는 최적 응집제 주입량에서의 Zeta potential은 원수탁도가 5NTU일 경우 Alum, PAC 및 PACS 모두 -20mV∼-15mV사이였으며, 원수 탁도가 10NTU인 경우에는 0∼0.5mV 범위에 있는 것으로 나타나 응집제 종류 및 주입량이 상이하더라도 응집효율이 가장 양호한 상태에서의 Zeta potential은 일정한 범위내에 있는 것으로 나타났다.